Macros Meseguer, a European full-time culture expert, has shown that using the GERI full-time culture incubator,
Clinical pregnancy rate increased by at least 15%, and live birth rate increased by at least 5.8%
15 years of experience in assisted reproductive technology, focusing on product development and registration
Beikang Medical, after fifteen years of intensive cultivation, has been committed to focusing on product research and development and registration, especially in the field of assisted reproduction. With profound accumulation and unremitting efforts, it finally ushered in the glorious moment of registration and certification of its product pipeline in 2024. This series of innovative technologies and products not only injects fresh vitality into the clinical practice of assisted reproduction, but also fills the gap in ecuador telegram data domestic reliance on imports and lack of registered products in many key areas, demonstrating Beikang Medical's outstanding contribution to promoting the advancement of domestic reproductive health technology.
To date, Beikang Medical has steadily built up the scale capabilities of the leading industrial chain and achieved a full-scale layout from research and development to registration and then to market application. In particular, in 2024, the company successfully completed the registration and certification of most of its core products, which marked a solid step forward for Beikang Medical in technology research and development and product transformation. Looking ahead to 2025, as the commercialization process of these innovative products accelerates, Beikang Medical will officially enter the fast lane of rapid commercialization, open a new chapter, and lead the future development of the assisted reproductive field.